Home > Products > CD28 & EGFR
> Recombinant Anti-CD28 x Anti-EGFR Bispecific Antibody (Tandem scFv-Fc)
Recombinant Anti-CD28 x Anti-EGFR Bispecific Antibody (Tandem scFv-Fc) (CAT#: BSFVF-058)
Recombinant Anti-CD28 x Anti-EGFR Bispecific Antibody (Tandem scFv-Fc) is designed to be expressed as a homodimer, which has 2+2 antigen-binding valency. This format consists of one Fc region and two tandem scFv fragments, in which the anti-CD28/EGFR tandem scFv is fused to the Fc domain. The engineered fragment format is used to extend the half-life. This BsAb can retarget T cells to tumor cells. It is designed for the research of Head and neck cancer; Colorectal cancer (CRC); Glioblastoma multiforme (GBM); Squamous cancer; Glioblastoma; Medulloblastoma; Non-small cell lung cancer (NSCLC); Renal cell cancer (RCC); Solid tumors therapy.
Head and neck cancer; Colorectal cancer (CRC); Glioblastoma multiforme (GBM); Squamous cancer; Glioblastoma; Medulloblastoma; Non-small cell lung cancer (NSCLC); Renal cell cancer (RCC); Solid tumors
There are currently no customer reviews or questions for Recombinant Anti-CD28 x Anti-EGFR Bispecific Antibody (Tandem scFv-Fc) (BSFVF-058). Click the button below to contact us or submit your feedback about this product.